Volume 3, Issue 1, March 2018, Page: 12-16
Congenital Nasolacrimal Duct Obstruction – An Updated Review
Kamrul Laila, Bangladesh Secretariat Clinic, Dhaka, Bangladesh
Golam Mohammad Abul Monsur Khan, Department of Ophthalmology, Bangladesh Secretariat Clinic, Dhaka, Bangladesh
Imran Sarker, National Institute of Neurosciences and Hospital, Dhaka, Bangladesh
Shahria Sattar, Bangladesh Secretariat Clinic, Dhaka, Bangladesh
Received: Mar. 6, 2018;       Accepted: Mar. 26, 2018;       Published: May 5, 2018
DOI: 10.11648/j.ijovs.20180301.13      View  828      Downloads  36
Abstract
Congenital nasolacrimal duct obstruction is the blockage of the lacrimal drainage system. It occurs in approximately 5 to 20% of normal newborn infants. A history of tearing and mucous or mucopurulent discharge and recurrent pink eye in a young child should alert the physician to the presence of nasolacrimal duct obstruction. Usually this condition is diagnosed clinically, though there are some investigations for precise diagnosis. Treatment is supportive and non surgical in 90 to 95% of cases, only 5 to 10% patients need surgical intervention. Outcome is good with minimal complications.
Keywords
Congenital Nasolacrimal Duct Obstruction, Lacrimal Apparatus, Tears, Sac Massage, Probing, Stenting, Dacryocystorhinostomy
To cite this article
Kamrul Laila, Golam Mohammad Abul Monsur Khan, Imran Sarker, Shahria Sattar, Congenital Nasolacrimal Duct Obstruction – An Updated Review, International Journal of Ophthalmology & Visual Science. Vol. 3, No. 1, 2018, pp. 12-16. doi: 10.11648/j.ijovs.20180301.13
Copyright
Copyright © 2018 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Bernardino CR. Evaluating Epiphora: Nothing to Cry About. Review of Ophthalmology, 2011; 9(6): 17-21.
[2]
Espinoza GM,LuederGT.Outcomes in children with nasolacrimal duct obstruction: Significance of persistent symptoms while stents are in place. Journal of AAPOS, 2007; 11(2): 187-188.
[3]
Paul TO. Medical management of congenital nasolacrimal duct obstruction. J PediatrOphthalmol and Strabismus. 1985; 22:68-70.
[4]
Haque SM. Diseases of the lacrimal apparatus, BasicOphthalmology, 1st edition, Capital book centre: Nilkhet, Dhaka; 2009. 84-85.
[5]
Paul TO, Shepherd R. Congenital nasolacrimal duct obstruction: Natural history and the timing of optimal intervention. J PediatrOphthalmol Strabismus. 1994; 31: 362-367.
[6]
Lim CS, Martin F, Beckenham T, Cumming RG. Nasolacrimal duct obstruction in children. J AAPOS, 2004;8:466-72.
[7]
Gregg T L. Endoscopic Treatment of Intranasal Abnormalities Associated With Nasolacrimal Duct Obstruction. J AAPOS, 2004; 8: 128-132.
[8]
Casady DR, Meyer DR, Simon JW, et al. Stepwise treatment paradigm for congenital nasolacrimal duct obstruction. Ophthal Plast Reconstr Surg 2006; 22: 243–7.
[9]
Akintunde J K, Siemuri E O, Bello I J et al.Tears Production: Implication for Health Enhancement. Open Access Scientific Reports, 2012; 1(10): 1-8.
[10]
Nelson, LB, Calhoun, JH, Menduke, H. Medical management of congenital nasolacrimal duct obstruction.Ophthalmology. 1985; 92:1187-1190.
[11]
Petersen, RA, Robb, RM. The natural history of congenital obstruction of the nasolacrimal duct. J PediatrOphthalmol and Strabismus. 1978; 15:246-250.
[12]
Thomas K. McInerny, MD, FAAP, ed. 2009. American Academy of Pediatrics Textbook of Pediatric Care. Elk Grove Village, IL. American Academy of Pediatrics, 1706-1710.
[13]
MacEwen, CJ, Young, JDH. The fluorescein disappearance test (FDT): an evaluation of its use in infants. J PediatrOphthalmol and Strabismus. 1991; 28:302-305.
[14]
Nozomi M, Satoshi G, Shin Y et al. High-resolution dacryoendoscopy for observation for pediatric lacrimal duct obstruction. American Journal of Ophthalmology Case Reports, 2016; 1: 23-25.
[15]
Zhang C, Yu G, Cui Y et al. Anatomical Characterization of the Nasolacrimal Canal Based on Computed Tomography in Children With Complex Congenital Nasolacrimal Duct Obstruction. , 2017; 54(4):238-243.
[16]
Ciftci F, Akman A, Sonmez M, et al. Systematic, combinedtreatment approach to nasolacrimal duct obstruction in different age groups. Eur J Ophthalmol 2000; 10:324–9.
[17]
Hossain KA,Rashid MA, Islam AKMR et al. Hydrostatic Message is an Effective Measure in Canalization of Congenital Naso-Lacrimal Duct Obstruction. Faridpur Med. Coll. J, 2015;10(2):50-51.
[18]
Simson JW, Aaby AA, Drack AV et al. The Lacrimal Drainage System. Pediatric Ophthalmology and strabismus: American Academy of Ophthalmology, 2010, 241-245.
[19]
Kushner, Burton J. Congenital Nasolacrimal System Obstruction. Arch Ophthalmol,1982;100:597-600.
[20]
Pediatric Eye Disease Investigator Group. Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years. Ophthalmology. 2008; 115: 577–584.
[21]
Kashkouli MB, Beigi B, Parvaresh MM, Kassaee A, Tabatabaee Z. Late and very late initial probing for congenital nasolacrimal duct obstruction: What is the cause of failure? Br J Ophthalmol 2003; 87: 1151-3.
[22]
Robb, Richard. Success rates of nasolacrimal duct probing at time intervals after 1 year of age. Ophthalmology. 1998; 105: 1307-1310.
[23]
Pediatric Eye Disease Investigator Group. Repeat probing for treatment of persistent nasolacrimal duct obstruction. J AAPOS. 2009; 13: 306-307.
[24]
Petris C, Liu D. Probing for congenital nasolacrimal duct obstruction. Cochrane Database Syst Rev., 2017 Jul 12; 7: 109-111.
[25]
Engel JM, Hichie-Schmidt C, Khammar A et al. Monocanalicularsilastic intubation for the initial correction of congenital nasolacrimal duct obstruction. J AAPOS 2007; 11: 183-186.
[26]
Pediatric Eye Disease Investigator Group. Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age.J AAPOS., 2008;12:451-455.
[27]
Gunton KB, Chung CW, Schnall BM, Prieto D, Wexler A, Koller HP.Comparison of balloon dacryocystoplasty to probing as the primary treatment of congenital nasolacrimal duct obstruction.J AAPOS. 2001; 5: 139-142.
[28]
Barnes EA, Abou-Rayyah Y, Rose GE. Pediatric dacryocystorhinostomy for nasolacrimal duct obstruction. Ophthalmology 2001; 108: 1562-1564.
[29]
Komınek P, Cervenka S, Matousek P, Pniak T, Zelenik Z. Primary pediatric endonasaldacryocystorhinostomy- a review of 58 procedures. Int J PedOtorhinolaryngology. 2010; 74: 661-664.
[30]
Singh S, Ali MJ, Paulsen F. A review on use of botulinum toxin for intractable lacrimal drainage disorders. Int Ophthalmol. 2017 Aug 1. doi: 10.1007/s10792-017-0661-9. [Epub ahead of print]
[31]
Ramkumar VA, Agarkar S, Mukherjee B. Nasolacrimal duct obstruction: Does it really increase the risk of amblyopia in children? Indian J Ophthalmol. 2016 Jul; 64 (7):496-499.
Browse journals by subject